-
Product Insights
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Propionic Acidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Propionic Acidemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Familial Amyloid Neuropathies Pipeline Drugs Market Report Overview Familial amyloid neuropathy is a slowly progressive condition characterized by the buildup of abnormal deposits of a protein called amyloid (amyloidosis) in the body's organs and tissues. Symptoms include numbness, tingling, pins, and needles in the feet and hands, weakness and pain in the arms and legs, loss of sensation, urinary retention, reduced sweating, ankle swelling, fatigue, nausea, weight loss, dizziness, and fainting. The Familial Amyloid Neuropathies pipeline drugs market research report...
-
Product Insights
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hyperglycemia Pipeline Drugs Development Market Report Overview Hyperglycemia is a condition that occurs when blood glucose levels get too high. Several factors can contribute to hyperglycemia, including food and physical activity choices, illness, non-diabetes medications, or not taking enough glucose-lowering medication. Symptoms include frequent urination, blurred vision, fatigue headache, nausea and vomiting, dry mouth, coma and confusion. Treatment includes anti-hyperglycemic therapy and insulin therapy. The Hyperglycemia pipeline drugs market research report provides comprehensive information on the therapeutics under development for...
-
Product Insights
Hyperinsulinemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hyperinsulinemia Drugs Development Market Report Overview Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. Insulin resistance is the primary cause of hyperinsulinemia. Symptoms include weight gain, anxiety, fatigue, and frequent hunger. The Hyperinsulinemia pipeline market research report provides comprehensive information on the therapeutics under development for Hyperinsulinemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pituitary ACTH Hypersecretion Pipeline Drugs Market Report Overview Cushing’s disease is a condition that results from hypersecretion of adrenocorticotropic hormone (ACTH) due to a pituitary gland tumor. Symptoms include acne or skin infections, backache, mental changes (such as depression, anxiety, or changes in behavior), menstrual disorders, and weight gain. Treatment includes radiation, chemotherapy, and the use of certain hormone-inhibiting drugs. The pituitary ACTH hypersecretion pipeline products market research report provides comprehensive information on the therapeutics under development for pituitary ACTH...
-
Product Insights
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Familial Chylomicronemia (Type I Hyperlipoproteinemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Familial Chylomicronemia (Type I Hyperlipoproteinemia), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteoporosis Pipeline Drugs Market Overview Osteoporosis signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone fracture that occurs much more easily than expected. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications. The Osteoporosis pipeline drugs market research report provides an analysis of the Osteoporosis drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type....
-
Product Insights
Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Postmenopausal osteoporosis is the most common form of osteoporosis. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. The Post Menopausal Osteoporosis pipeline drugs market research report outlays comprehensive information on the Post Menopausal Osteoporosis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type, that are being developed by companies/universities. It also reviews key players involved in Post Menopausal Osteoporosis targeted therapeutics development...
-
Product Insights
Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pompe disease is an inherited disorder caused by a defect in a gene called GAA. The GAA gene is responsible for the production of the GAA enzyme (acid alpha-glucosidase). The Pompe Disease pipeline drugs market research report outlays comprehensive information on the Pompe Disease targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type, that are being developed by companies/universities. It also reviews key players involved in Pompe Disease...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.